Diisopropyl Cyanomethylphosphonate,
Brand names,
Diisopropyl Cyanomethylphosphonate,
Analogs
Diisopropyl Cyanomethylphosphonate,
Brand Names Mixture
Diisopropyl Cyanomethylphosphonate,
Chemical_Formula
C6H14FO3P
Diisopropyl Cyanomethylphosphonate,
RX_link
No information avaliable
Diisopropyl Cyanomethylphosphonate,
fda sheet
Diisopropyl Cyanomethylphosphonate,
msds (material safety sheet)
Diisopropyl Cyanomethylphosphonate,
Synthesis Reference
No information avaliable
Diisopropyl Cyanomethylphosphonate,
Molecular Weight
184.146 g/mol
Diisopropyl Cyanomethylphosphonate,
Melting Point
-82 oC
Diisopropyl Cyanomethylphosphonate,
H2O Solubility
1.54E+004 mg/L
Diisopropyl Cyanomethylphosphonate,
State
Liquid
Diisopropyl Cyanomethylphosphonate,
LogP
1.13
Diisopropyl Cyanomethylphosphonate,
Dosage Forms
No information avaliable
Diisopropyl Cyanomethylphosphonate,
Indication
For use in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia.
Diisopropyl Cyanomethylphosphonate,
Pharmacology
Isoflurophate is used as ocular drops in the treatment of chronic glaucoma. Isoflurophate is an organophosphorus compound that acts as an irreversible cholinesterase inhibitor. As such, it displays parasympathomimetic effects. Isoflurophate is used in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia. They may also be used in the diagnosis of certain eye conditions, such as accommodative esotropia. Isoflurophate damages the acetylcholinesterase enzyme and is therefore irreversible, however, pralidoxime can displace organophosphates such as isoflurophate from acetylcholinesterase, but only if administered before isoflurophate damages (alkylates) the enzyme.
Diisopropyl Cyanomethylphosphonate,
Absorption
No information avaliable
Diisopropyl Cyanomethylphosphonate,
side effects and Toxicity
Signs of overdose include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth.
Diisopropyl Cyanomethylphosphonate,
Patient Information
No information avaliable
Diisopropyl Cyanomethylphosphonate,
Organisms Affected
Humans and other mammals